Capital-intensive Aerospace & Defense (A&D) companies require a deliberate capital strategy. Front-loaded spend and the lumpy nature of contracts can create cash gaps and potential for dilution without a strategic financing plan. Start by planning around four structural realities:
- Capital intensity: Capex-intensive, hardware-forward defense companies require substantial upfront investment in non-recurring engineering (NRE), equipment, facilities and inventory often before generating material revenue.
- Long timelines: The path from prototype to product launch can take years of rigorous testing and validation, and the government procurement process (source selection, contracting, budgeting) can also take years.
- Nonlinear, milestone-driven revenue: Revenue often arrives in large, potentially unpredictable chunks tied to government awards or subcontractor relationships with 30- to 180-day payment cycles—creating valleys of death between awards, contract milestones, collections and capital outflows required to perform on a contract.
- Regulatory compliance load: Export controls (International Traffic in Arms Regulations (ITAR), Export Administration Regulations (EAR)), cybersecurity mandates (Cybersecurity Maturity Model Certification (CMMC)) and facility clearances are examples of regulatory requirements that can add potentially significant costs.
Founders should design an efficient capitalization plan on day one. The ongoing role of debt can be critical—capex-intensive defense tech companies often rely on debt throughout their entire life cycle, and understanding when and how to use different debt instruments is a key consideration when assessing ownership preservation, momentum and optionality.
While debt isn't the answer for every business, it is a highly useful tool specific to a defense tech company's needs and goals. Our goal is to shed light on scenarios where companies can manage leverage to improve capital efficiency and derisk their businesses.
This playbook equips you with a clear financing road map built for the realities of a hardware-focused startup's journey. Use it to navigate available options, build a resilient capital stack and plan proactively at every stage.
Chapter 1: Building the foundation
Early-stage funding for defense tech companies can come from a variety of sources including angel investors, government grants, SBIR/STTR awards and pre-seed venture capital. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are a common starting point, offering both capital and validation within the defense ecosystem.
While the two programs are very similar, the main difference is that STTR requires a formal collaboration with a nonprofit research institution. Because they share the same three-phase structure and serve a similar purpose in the capital journey, we'll primarily refer to SBIR for simplicity. You can learn more about their specific differences here.
While SBIR awards provide crucial early funding, success can create a new challenge: a funding gap between finalizing a prototype and starting production. A Phase II award proves the technology works, but scaling to production can require $5 to $20 million for NRE like tooling, test fixtures, supply chain qualification and manufacturing infrastructure. This is where most companies building physical products need their first institutional equity round—often before they have any production revenue.
Not every defense tech company follows the SBIR/STTR route, however. Other paths to early validation and capital formation include direct equity, engagements with the Defense Innovation Unit (DIU), subcontracting under defense primes, and bootstrapped or angel funding.
Why your funding type doesn't change the commercialization timeline
Regardless of which type of initial funding your firm receives, none of these routes automatically shortens the commercialization timeline. You still have to navigate manufacturing ramps, bridge gaps in working capital and engage in thoughtful capital stacking.
Some founders think bypassing SBIR means hypergrowth. But manufacturing is manufacturing and working capital cycles are working capital cycles. The fundamentals don't change.
Successful companies use early-stage grants and contract awards to achieve validation milestones to attract institutional capital and bank debt. This preparation is important because reaching commercialization requires you to navigate the valleys of death between funding stages. Whether those gaps come between rounds of funding or SBIR/STTR phases, you'll probably need additional sources of capital to get across them. To ensure those transitions go smoothly, companies must secure private capital before they need it. (See Chapter 4: Why timing is everything.)
Chapter 2: The transition to institutional equity
Many firms seek equity funding as they progress to commercialization. For defense tech companies, seed and Series A+ funding rounds serve multiple purposes—validating your business beyond government programs, providing capital to scale operations and bringing investors and their often-vast relationships into your network.
- Example early-stage capital requirements:
- Seed round: $2 to $10 million (12 to 18 months runway)
- Series A: $10 to $25 million (manufacturing readiness)
The equity trade-off
Equity financing provides obvious benefits but also comes with certain considerations. Defense tech founders need to understand and plan around the trade-offs involved as early as possible.
Equity benefits
- Future repayment is aligned with founders, an exit through M&A or an IPO.
- Access to investor, supply chain, government and customer networks.
- Support for projects that are risky to underwrite.
Equity considerations
- Dilution: Multiple large equity rounds can leave founders with minimal ownership. Capex-intensive companies are especially exposed.
- Exit constraints: Equity financing puts pressure on your exit—the more equity you raise, the higher the bar for exit valuation.
The strategic role of debt
Debt financing can be a strategic advantage, not just for founders but for all equity shareholders—and should be a critical consideration when building a long-term financing plan.
Debt benefits
- Reduced dilution, healthier cap tables and reasonable valuation expectations
- Bridge payment cycles and contract delays without raising equity under duress
- Signal of capital efficiency and planning discipline to future investors
When to use equity versus debt
Building a capital structure can be a complex task, but the core principle is to align the type of capital with its purpose. Equity provides maximum flexibility for dynamic, high-risk phases of company building. Debt is a more structured product that should be reserved for clear-cut use cases. Both create value and enable growth, but equity excels when you need adaptability, while debt works best for predictable, defined capital requirements.